These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 23321564)

  • 21. Synthesis and antiproliferative activity of some ellipticine-like 11H-pyrido[a]carbazole derivatives.
    Ferlin MG; Gia O; Dalla Via L
    ChemMedChem; 2011 Oct; 6(10):1872-83. PubMed ID: 21826796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel antitumor indolizino[6,7-b]indoles with multiple modes of action: DNA cross-linking and topoisomerase I and II inhibition.
    Chaniyara R; Tala S; Chen CW; Zang X; Kakadiya R; Lin LF; Chen CH; Chien SI; Chou TC; Tsai TH; Lee TC; Shah A; Su TL
    J Med Chem; 2013 Feb; 56(4):1544-63. PubMed ID: 23360284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An efficient one-pot synthesis of benzothiazolo-4β-anilino-podophyllotoxin congeners: DNA topoisomerase-II inhibition and anticancer activity.
    Kamal A; Kumar BA; Suresh P; Shankaraiah N; Kumar MS
    Bioorg Med Chem Lett; 2011 Jan; 21(1):350-3. PubMed ID: 21144748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Interactions of Selected Olivacine Derivatives with DNA and Topoisomerase II.
    Tylińska B; Dobosz A; Spychała J; Cwynar-Zając Ł; Czyżnikowska Ż; Kuźniarski A; Gębarowski T
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of inhibitory effects of benzothiazole and 3-amino-benzothiazolium derivatives on DNA topoisomerase II by molecular modeling studies.
    Aki-Yalcin E; Ertan-Bolelli T; Taskin-Tok T; Ozturk O; Ataei S; Ozen C; Yildiz I; Yalcin I
    SAR QSAR Environ Res; 2014; 25(8):637-49. PubMed ID: 25027467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel nalidixic acid derivatives targeting topoisomerase II enzyme; Design, synthesis, anticancer activity and effect on cell cycle profile.
    Khalil OM; Gedawy EM; El-Malah AA; Adly ME
    Bioorg Chem; 2019 Mar; 83():262-276. PubMed ID: 30391699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, antitumor activity, and structure-activity relationship study of trihydroxylated 2,4,6-triphenyl pyridines as potent and selective topoisomerase II inhibitors.
    Karki R; Park C; Jun KY; Jee JG; Lee JH; Thapa P; Kadayat TM; Kwon Y; Lee ES
    Eur J Med Chem; 2014 Sep; 84():555-65. PubMed ID: 25062006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topoisomerase as target for antibacterial and anticancer drug discovery.
    Kathiravan MK; Khilare MM; Nikoomanesh K; Chothe AS; Jain KS
    J Enzyme Inhib Med Chem; 2013 Jun; 28(3):419-35. PubMed ID: 22380774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of dihydroxylated 2,4-diphenyl-6-thiophen-2-yl-pyridine as a non-intercalative DNA-binding topoisomerase II-specific catalytic inhibitor.
    Jun KY; Kwon H; Park SE; Lee E; Karki R; Thapa P; Lee JH; Lee ES; Kwon Y
    Eur J Med Chem; 2014 Jun; 80():428-38. PubMed ID: 24796883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids: synthesis, physicochemical properties, anticancer and topoisomerase I and II inhibitory activity.
    Abdel-Aziz M; Park SE; Abuo-Rahma Gel-D; Sayed MA; Kwon Y
    Eur J Med Chem; 2013 Nov; 69():427-38. PubMed ID: 24090914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of human DNA topoisomerase IIα by two novel ellipticine derivatives.
    Vann KR; Ergün Y; Zencir S; Oncuoglu S; Osheroff N; Topcu Z
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1809-12. PubMed ID: 26906637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-based design, synthesis and biological testing of etoposide analog epipodophyllotoxin-N-mustard hybrid compounds designed to covalently bind to topoisomerase II and DNA.
    Yadav AA; Wu X; Patel D; Yalowich JC; Hasinoff BB
    Bioorg Med Chem; 2014 Nov; 22(21):5935-49. PubMed ID: 25282653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intoplicine (RP 60475) and its derivatives, a new class of antitumor agents inhibiting both topoisomerase I and II activities.
    Riou JF; Fossé P; Nguyen CH; Larsen AK; Bissery MC; Grondard L; Saucier JM; Bisagni E; Lavelle F
    Cancer Res; 1993 Dec; 53(24):5987-93. PubMed ID: 8261412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual Inhibitors of Human DNA Topoisomerase II and Other Cancer-Related Targets.
    Skok Ž; Zidar N; Kikelj D; Ilaš J
    J Med Chem; 2020 Feb; 63(3):884-904. PubMed ID: 31592646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of Indolo[3,2-
    Wang B; Wu S; Jia S; Ruan X; Sheng C; Zhou Q
    J Med Chem; 2024 Aug; 67(16):14155-14174. PubMed ID: 39106476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. l,8-Naphthalimide based DNA intercalators and anticancer agents. A systematic review from 2007 to 2017.
    Tomczyk MD; Walczak KZ
    Eur J Med Chem; 2018 Nov; 159():393-422. PubMed ID: 30312931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, Synthesis, and Anticancer Evaluation of Novel Indole Derivatives of Ursolic Acid as Potential Topoisomerase II Inhibitors.
    Li AL; Hao Y; Wang WY; Liu QS; Sun Y; Gu W
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent developments of DNA poisons--human DNA topoisomerase IIα inhibitors--as anticancer agents.
    Pogorelčnik B; Perdih A; Solmajer T
    Curr Pharm Des; 2013; 19(13):2474-88. PubMed ID: 23363399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New benzoxanthone derivatives as topoisomerase inhibitors and DNA cross-linkers.
    Cho HJ; Jung MJ; Woo S; Kim J; Lee ES; Kwon Y; Na Y
    Bioorg Med Chem; 2010 Feb; 18(3):1010-7. PubMed ID: 20093033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of pharmacologically important naphthoquinones and anticancer activity of 2-benzyllawsone through DNA topoisomerase-II inhibition.
    Kumar BS; Ravi K; Verma AK; Fatima K; Hasanain M; Singh A; Sarkar J; Luqman S; Chanda D; Negi AS
    Bioorg Med Chem; 2017 Feb; 25(4):1364-1373. PubMed ID: 28094224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.